Indeed, RNA-sequencing data for SCLC patients (GSE60052) revealed that PPAT expression was greater in tumor than in normal tissue, whereas GLS1 expression was lower in tumor than in normal tissue (Fig. 7a). This evidence concerns the gene PPAT and small cell lung carcinoma.